View Financial HealthCosnine 配当と自社株買い配当金 基準チェック /06Cosnine配当金を支払った記録がありません。主要情報n/a配当利回り0%バイバック利回り総株主利回り0%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Koreaお知らせ • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea分析記事 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.お知らせ • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.お知らせ • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.お知らせ • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.お知らせ • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.お知らせ • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.お知らせ • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.お知らせ • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.お知らせ • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listingお知らせ • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.お知らせ • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.決済の安定と成長配当データの取得安定した配当: A082660の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A082660の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Cosnine 配当利回り対市場A082660 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A082660)n/a市場下位25% (KR)0.9%市場トップ25% (KR)3.5%業界平均 (Electronic)0.5%アナリスト予想 (A082660) (最長3年)n/a注目すべき配当: A082660は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: A082660は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: A082660の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A082660が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/11/03 22:48終値2024/08/07 00:00収益2024/06/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cosnine Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Mina LeeiM Securities
お知らせ • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
お知らせ • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
分析記事 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.
Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
お知らせ • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
お知らせ • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.
Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.
お知らせ • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
お知らせ • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.
お知らせ • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
お知らせ • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.
Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.
お知らせ • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.
お知らせ • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listing
お知らせ • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.
お知らせ • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.